Maquet Critical Care AB
$2.6K 5 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
EDW Pharma, Inc.
EDW Pharma, Inc. reported $2,611.03 across General Payments, Research, and Ownership to 23 physicians and teaching hospitals across 23 transactions.
- $2.6K Below-median payer
- All-tracks total
- 23 Below-median volume
- Transactions
- 23 Below-median reach
- Recipients
- +$1.5K
- General Payments vs PY2023
EDW Pharma, Inc. reported $2,611.03 across all CMS Open Payments tracks (General + Research + Ownership) to 23 physicians and teaching hospitals in Program Year 2024 - ranking #1773 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,611.03, averaging $113.52 per recipient.
EDW Pharma, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer edw-pharma-inc EDW Pharma, Inc.
$2.6K · #1773/1,925 · 0.0% industry · PY2024
- TOT $2.6K
- RANK #1773
- SHARE 0.0%
- TXN 23
- RCP 23
- CAT 1
- GEN $2.6K
- ΔGEN +$1.5K
- TOP1 13.5%
- PY 2024
Volume peers
Nearest volume peer: Maquet Critical Care AB ($2.6K)
EDW Pharma, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
EDW Pharma, Inc.'s CMS-reported General Payments increased by $1.5K (+136.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: EDW PHARMA, INC.PY2023: EDW PHARMA, INC.PY2024: EDW Pharma, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,105.15
- PY2024
- $2,611.03
What the Data Shows for EDW Pharma, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For EDW Pharma, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
"Food and Beverage" leads the 1-category general-payment breakdown below at $2.6K (100.0% of General Payments, 23 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
EDW Pharma, Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $2.6K, 100.0% of General Payments.
How EDW Pharma, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $2.6K | 23 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,586.19 (60.7%) of $2,611.03 in this company's General Payments records across 20 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for EDW Pharma, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Kevin Callerame
$351.62 across 1 reported transactions
- 2
Aimee Garza
$342.72 across 1 reported transactions
- 3
Er-Kai Gao
$331.13 across 3 reported transactions
- 4
Christopher Owen Edwards
$292.24 across 1 reported transactions
- 5
Vahid Tohidi
$268.48 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
EDW Pharma, Inc. ranks #1773 of 1,925 by total payments (bottom 8% by spend) but is notably more concentrated than that alone would suggest -- #1,062 of 1,838 by HHI (bottom 42% least concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- USA Angelalign Technology Corp : $100.0K total payments, HHI 930
- IntrinsiQ Specialty Solutions, Inc. : $1.3K total payments, HHI 926
- Precision Medical Products Inc. : $832.29 total payments, HHI 924
- CPM Medical Consultants, LLC : $2.4K total payments, HHI 919
- Acessa Health Inc. : $767.2K total payments, HHI 919
- Ortho Development Corporation : $3.6M total payments, HHI 918
- EDW Pharma, Inc. (this company) : $2.6K total payments, HHI 916
- Onkos Surgical, Inc. : $402.3K total payments, HHI 915
- Kinex Medical Company LLC : $133.04 total payments, HHI 915
- Choice Spine, LLC : $1.0M total payments, HHI 912
- SOMAVAC Medical Solutions, Inc. : $2.8K total payments, HHI 906
- Ares Trading SA : $254.3K total payments, HHI 902
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as EDW Pharma, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about EDW Pharma, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with EDW Pharma, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Joline Medical Inc
$2.6K 5 recipients
Compare payment profiles
Xiros Limited
$2.6K 1 recipients
Compare payment profiles
McKesson Medical-Surgical, Inc.
$2.6K 74 recipients
Compare payment profiles
Kettenbach LP
$2.6K 122 recipients
Compare payment profiles
Henry Schein Puerto Rico, Inc.
$2.6K 37 recipients
Compare payment profiles
Put this to use
EDW Pharma, Inc. ranks #1773 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just EDW Pharma, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.